Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

Article Types

Countries / Regions

Search Results (50)

Search Parameters:
Keywords = anti-human trafficking

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
37 pages, 9132 KiB  
Perspective
The Evidence That Brain Cancers Could Be Effectively Treated with In-Home Radiofrequency Waves
by Gary W. Arendash
Cancers 2025, 17(16), 2665; https://doi.org/10.3390/cancers17162665 - 15 Aug 2025
Viewed by 409
Abstract
There is currently no effective therapeutic capable of arresting or inducing regression of primary or metastatic brain cancers. This article presents both pre-clinical and clinical studies supportive that a new bioengineered technology could induce regression and/or elimination of primary and metastatic brain cancers [...] Read more.
There is currently no effective therapeutic capable of arresting or inducing regression of primary or metastatic brain cancers. This article presents both pre-clinical and clinical studies supportive that a new bioengineered technology could induce regression and/or elimination of primary and metastatic brain cancers through three disease-modifying mechanisms. Transcranial Radiofrequency Wave Treatment (TRFT) is non-thermal, non-invasive and self-administered in-home to safely provide radiofrequency waves to the entire human brain. Since TRFT has already been shown to stop and reverse the cognitive decline of Alzheimer’s Disease in small studies, evidence is provided that three key mechanisms of TRFT action, alone or in synergy, could effectively treat brain cancers: (1) enhancement of brain meningeal lymph flow to increase immune trafficking between the brain cancer and cervical lymph nodes, resulting in a robust immune attack on the brain cancer; (2) rebalancing of the immune system’s cytokines within the brain or brain cancer environment to decrease inflammation therein and thus make for an inhospitable environment for brain cancer growth; (3) direct anti-proliferation/antigrowth affects within the brain tumor microenvironment. Importantly, these mechanisms of TRFT action could be effective against both visualized brain tumors and those that are yet too small to be identified through brain imaging. The existing animal and human clinical evidence presented in this perspective article justifies TRFT to be clinically tested immediately against both primary and metastatic brain cancers as monotherapy or possibly in combination with immune checkpoint inhibitors. Full article
(This article belongs to the Special Issue Emerging Research on Primary Brain Tumors)
Show Figures

Figure 1

22 pages, 4781 KiB  
Article
Promoting Immune Response of Human Vascular Endothelial Cells by Bevacizumab: Insights into the Immune Supportive Role of Anti-VEGF Therapy
by Haiyan Jia, Anna Nowocin, Chris Burns and Meenu Wadhwa
Int. J. Mol. Sci. 2025, 26(13), 6280; https://doi.org/10.3390/ijms26136280 - 29 Jun 2025
Viewed by 568
Abstract
Compelling clinical evidence strongly indicates that anti-angiogenesis therapeutics including Bevacizumab, a humanised anti-VEGF mAb, can alleviate the resistance to immunotherapy. We explored the direct modulation of Bevacizumab on endothelial cell (EC) immune response including surface expression of adhesion and MHC molecules and EC-elicited [...] Read more.
Compelling clinical evidence strongly indicates that anti-angiogenesis therapeutics including Bevacizumab, a humanised anti-VEGF mAb, can alleviate the resistance to immunotherapy. We explored the direct modulation of Bevacizumab on endothelial cell (EC) immune response including surface expression of adhesion and MHC molecules and EC-elicited proliferation of immune cells under inflammatory conditions. Flow cytometry showed that addition of VEGF inhibited TNF-α stimulation of expression of ICAM-1 and VCAM-1 on HUVECs, whereas Bevacizumab enhanced this TNF-α-stimulated expression. The presence of MHC Class I on HUVECs was decreased by VEGF and increased by TNF-α, respectively. Bevacizumab reversed VEGF downregulation and promoted TNF-α upregulation of MHC class I expression, suggesting that anti-VEGF treatment can boost the endothelial immunological reaction, a prerequisite for immune cell trafficking. Functionally, real-time monitoring of the proliferation of human PBMCs co-cultured on HUVEC monolayers over 3 days showed opposing effects on the proliferation of PBMCs between VEGF and TNF-α. Consistently, Bevacizumab antagonised VEGF suppression and sensitized TNF-α activation of PBMC growth over the time course. In line with these findings, Bevacizumab increased the surface expression of CD69 on VEGF-treated T cells collected from PBMCs after 3-day co-cultures with HUVECs. Furthermore, the proliferation of CD3+, CD8+ and CD4+ T cells was promoted via Bevacizumab. Collectively, this study demonstrates that targeting VEGF can enhance the immune response of ECs required for T cell recruitment. Our findings provide insights to a deeper understanding of increased vascular inflammatory response conferred by anti-VEGF treatment in addition to inhibiting angiogenesis, which supports its favourable dual role in the positive immunological synergism with immunotherapy. Full article
(This article belongs to the Section Molecular Immunology)
Show Figures

Figure 1

21 pages, 318 KiB  
Article
Child-Centered Anti-Trafficking Approaches in Mediterranean Migration Routes: Italy and Turkey
by Ezgi Yaman Kennedy
Soc. Sci. 2024, 13(12), 700; https://doi.org/10.3390/socsci13120700 - 23 Dec 2024
Cited by 1 | Viewed by 4831
Abstract
Introduction: Child trafficking is a clear violation of human rights, robbing minors of their fundamental entitlements. These encompass the right to personal identity, familial bonds, cultural heritage, access to healthcare and proper nourishment, education, freedom of speech, and the assurance of safety and [...] Read more.
Introduction: Child trafficking is a clear violation of human rights, robbing minors of their fundamental entitlements. These encompass the right to personal identity, familial bonds, cultural heritage, access to healthcare and proper nourishment, education, freedom of speech, and the assurance of safety and security. Children and young people, given their inherent vulnerability and limited access to support networks, frequently struggle to safeguard themselves effectively. This predicament presents traffickers with opportunities to exploit and manipulate them. Therefore, it is essential for professionals across various sectors—including education, healthcare, protective and social services, as well as the justice system—to undergo comprehensive training and be integrated into a robust social protection system. This preparation should equip them to conduct screenings, accurately assess needs, and adhere to international guidelines when addressing cases of child trafficking. Aim: The aim of this study is to explore the child-centered anti-trafficking approaches employed by Italy and Turkey, situated along migration pathways in the Mediterranean region and experiencing significant regular and irregular migration flows in recent years. Both nations fall within the classification of southern European welfare regimes. Methodology: This research specifically delves into the social protection policies aimed at children and young victims established by these two countries. Carried out between 1 February 2020 and 20 May 2021, this study employed a semi-structured interview approach, conducting qualitative in-depth interviews in both Italy and Turkey. This research targeted experts from various disciplines engaged in combating human trafficking in both countries, with a total sample size of 46 participants, comprising 15 experts from Italy and 31 from Turkey. Grounded theory formed the basis of the study, with data analyzed using the MAXQDA 2020 Pro Analytics program, employing a multidisciplinary and empowerment approach. Results: The analysis yielded 2942 codes, 17 sub-themes, and four main themes. The study identified four main themes: (i) characteristics of child victims and vulnerable child groups, (ii) services provided to at-risk groups and child trafficking victims within the current national counter-trafficking framework, (iii) challenges encountered in delivering services to children and young individuals, and (iv) recommendations for establishing an effective and child-centered protection system. Discussion and Conclusion: It is imperative to ensure that victims of child trafficking have access to comprehensive social protection measures. It has been noted that both Italy and Turkey offer various services to victims of child trafficking, including in-kind and -cash social assistance, free legal aid, shelter services, access to education and healthcare, as well as prevention, awareness, and advocacy programs. However, there are also differences between the two countries in certain aspects. Recommendations aimed at addressing these differences can be developed by adhering to the minimum standards outlined in the Council of Europe Convention on Action against Trafficking in Human Beings. Full article
(This article belongs to the Special Issue Emerging Trends and Dimensions of Child Trafficking)
15 pages, 8448 KiB  
Review
The J Domain Proteins of Plasmodium knowlesi, a Zoonotic Malaria Parasite of Humans
by Michael O. Daniyan, Harpreet Singh and Gregory L. Blatch
Int. J. Mol. Sci. 2024, 25(22), 12302; https://doi.org/10.3390/ijms252212302 - 16 Nov 2024
Viewed by 2067
Abstract
Plasmodium knowlesi is a zoonotic form of human malaria, the pathology of which is poorly understood. While the J domain protein (JDP) family has been extensively studied in Plasmodium falciparum, and shown to contribute to malaria pathology, there is currently very limited [...] Read more.
Plasmodium knowlesi is a zoonotic form of human malaria, the pathology of which is poorly understood. While the J domain protein (JDP) family has been extensively studied in Plasmodium falciparum, and shown to contribute to malaria pathology, there is currently very limited information on the P. knowlesi JDPs (PkJDPs). This review provides a critical analysis of the literature and publicly available data on PkJDPs. Interestingly, the P. knowlesi genome encodes at least 31 PkJDPs, with well over half belonging to the most diverse types which contain only the signature J domain (type IIIs, 19) or a corrupted version of the J domain (type IVs, 2) as evidence of their membership. The more typical PkJDPs containing other domains typical of JDPs in addition to the J domain are much fewer in number (type IIs, 8; type Is, 2). This study indentifies PkJDPs that are potentially involved in: folding of newly synthesized or misfolded proteins within the P. knowlesi cytosol (a canonical type I and certain typical type IIs); protein translocation (a type III) and folding (a type II) in the ER; and protein import into mitochondria (a type III). Interestingly, a type II PkJDP is potentially exported to the host cell cytosol where it may recruit human HSP70 for the trafficking and folding of other exported P. knowlesi proteins. Experimental studies are required on this fascinating family of proteins, not only to validate their role in the pathology of knowlesi malaria, but also because they represent potential anti-malarial drug targets. Full article
Show Figures

Figure 1

17 pages, 3582 KiB  
Article
High-Throughput Screening of Antiviral Compounds Using a Recombinant Hepatitis B Virus and Identification of a Possible Infection Inhibitor, Skimmianine
by Mika Yoshita, Masaya Funaki, Tetsuro Shimakami, Masaki Kakuya, Kazuhisa Murai, Saiho Sugimoto, Shotaro Kawase, Koji Matsumori, Taro Kawane, Tomoki Nishikawa, Asuka Nakamura, Reo Suzuki, Atsuya Ishida, Narumi Kawasaki, Yuga Sato, Ying-Yi Li, Ariunaa Sumiyadorj, Kouki Nio, Hajime Takatori, Kazunori Kawaguchi, Kazuyuki Kuroki, Takanobu Kato, Masao Honda and Taro Yamashitaadd Show full author list remove Hide full author list
Viruses 2024, 16(8), 1346; https://doi.org/10.3390/v16081346 - 22 Aug 2024
Cited by 1 | Viewed by 1589
Abstract
We developed a novel hepatitis B virus (HBV) infection-monitoring system using a luminescent, 11-amino acid reporter (HiBiT). We performed high-throughput antiviral screening using this system to identify anti-HBV compounds. After the infection of primary human hepatocytes with the recombinant virus HiBiT-HBV, which contains [...] Read more.
We developed a novel hepatitis B virus (HBV) infection-monitoring system using a luminescent, 11-amino acid reporter (HiBiT). We performed high-throughput antiviral screening using this system to identify anti-HBV compounds. After the infection of primary human hepatocytes with the recombinant virus HiBiT-HBV, which contains HiBiT at its preS1, 1262 compounds were tested in a first screening using extracellular HiBiT activity as an indicator of viral infection. Following a second screening, we focused on the compound skimmianine, which showed a potent antiviral effect. When skimmianine was added at the same time as HiBiT-HBV infection, skimmianine inhibited HiBiT activity with EC50 of 0.36 pM, CC50 of 1.67 μM and a selectivity index (CC50:EC50 ratio) of 5,100,000. When skimmianine was added 72 h after HiBiT-HBV infection, the EC50, CC50 and selectivity index were 0.19 μM, 1.87 μM and 8.79, respectively. Time-lapse fluorescence imaging analysis using another recombinant virus, ReAsH-TC155HBV, with the insertion of tetra-cysteine within viral capsid, revealed that skimmianine inhibited the accumulation of the capsid into hepatocytes. Furthermore, skimmianine did not inhibit either attachment or internalization. These results imply that skimmianine inhibits the retrograde trafficking of the virus after internalization. This study demonstrates the usefulness of the recombinant virus, HiBiT-HBV, for high-throughput screening to identify anti-HBV compounds. Full article
(This article belongs to the Section Human Virology and Viral Diseases)
Show Figures

Graphical abstract

16 pages, 3813 KiB  
Article
Structural Characterization of Human Bufavirus 1: Receptor Binding and Endosomal pH-Induced Changes
by Mitchell Gulkis, Mengxiao Luo, Paul Chipman, Mario Mietzsch, Maria Söderlund-Venermo, Antonette Bennett and Robert McKenna
Viruses 2024, 16(8), 1258; https://doi.org/10.3390/v16081258 - 6 Aug 2024
Cited by 2 | Viewed by 1944
Abstract
Bufaviruses (BuV) are members of the Parvoviridae of the Protoparvovirus genus. They are non-enveloped, T = 1 icosahedral ssDNA viruses isolated from patients exhibiting acute diarrhea. The lack of treatment options and a limited understanding of their disease mechanisms require studying these viruses [...] Read more.
Bufaviruses (BuV) are members of the Parvoviridae of the Protoparvovirus genus. They are non-enveloped, T = 1 icosahedral ssDNA viruses isolated from patients exhibiting acute diarrhea. The lack of treatment options and a limited understanding of their disease mechanisms require studying these viruses on a molecular and structural level. In the present study, we utilize glycan arrays and cell binding assays to demonstrate that BuV1 capsid binds terminal sialic acid (SIA) glycans. Furthermore, using cryo-electron microscopy (cryo-EM), SIA is shown to bind on the 2/5-fold wall of the capsid surface. Interestingly, the capsid residues stabilizing SIA binding are conserved in all human BuVs identified to date. Additionally, biophysical assays illustrate BuV1 capsid stabilization during endo–lysosomal (pH 7.4–pH 4) trafficking and capsid destabilization at pH 3 and less, which correspond to the pH of the stomach. Hence, we determined the cryo-EM structures of BuV1 capsids at pH 7.4, 4.0, and 2.6 to 2.8 Å, 3.2 Å, and 2.7 Å, respectively. These structures reveal capsid structural rearrangements during endo–lysosomal escape and provide a potential mechanism for this process. The structural insights gained from this study will add to the general knowledge of human pathogenic parvoviruses. Furthermore, the identification of the conserved SIA receptor binding site among BuVs provides a possible targetable surface-accessible pocket for the design of small molecules to be developed as anti-virals for these viruses. Full article
(This article belongs to the Section Human Virology and Viral Diseases)
Show Figures

Figure 1

14 pages, 299 KiB  
Article
Excluded but Fighting: Where Are the Voices of Sex Workers and Their Allies in EU Anti-Trafficking Policymaking?
by Irena Ferčíková Konečná
Soc. Sci. 2024, 13(3), 148; https://doi.org/10.3390/socsci13030148 - 5 Mar 2024
Cited by 4 | Viewed by 4937
Abstract
The ‘end demand’ approach to prostitution has been popping up in Europe through the anti-trafficking debate and receives increasing attention on the international agenda. It is well recognized that improving workers’ rights, increasing unionization and collective bargaining coverage are effective strategies for tackling [...] Read more.
The ‘end demand’ approach to prostitution has been popping up in Europe through the anti-trafficking debate and receives increasing attention on the international agenda. It is well recognized that improving workers’ rights, increasing unionization and collective bargaining coverage are effective strategies for tackling trafficking. However, with regard to sexual exploitation, focus is not on these strategies but instead on the abolition of the entire sex industry with the help of criminal justice systems. In first decade after the Palermo Protocol (2000), international organizations (IGOs) promoted a human rights-based approach to tackling trafficking, aiming to balance the criminal justice focus of the protocol. This work guided states on how to maintain and protect human rights while combating human trafficking. However, the explosive issue of sex work/prostitution was minimized, with IGOs avoiding the topic due to the fragile consensus about the definition of human trafficking and state obligations. Meanwhile, sex workers’ collectives and unions globally and throughout Europe developed their own strategies on how to address widespread criminalization, discrimination, violence and exploitation, with no or very limited funding and resources—and without recognition of their work, experience and expertise. This article presents how the European Sex Workers’ Rights Alliance (ESWA) and other sex workers’ rights civil society organizations have sought to challenge the harmful impacts of the ‘end demand’ discourse and the criminalization of sex work in the name of anti-trafficking in Europe. Full article
(This article belongs to the Special Issue International Counter-Trafficking: A Zero-Sum Game?)
15 pages, 2960 KiB  
Article
Tyrosine Sulfation at Antibody Light Chain CDR-1 Increases Binding Affinity and Neutralization Potency to Interleukine-4
by Aaron M. D’Antona, Julie M. Lee, Melvin Zhang, Clarence Friedman, Tao He, Lidia Mosyak, Eric Bennett, Laura Lin, Maddison Silverman, Funi Cometa, Caryl Meade, Tyler Hageman, Eric Sousa, Justin Cohen, Kimberly Marquette, Darren Ferguson and Xiaotian Zhong
Int. J. Mol. Sci. 2024, 25(3), 1931; https://doi.org/10.3390/ijms25031931 - 5 Feb 2024
Cited by 3 | Viewed by 2495
Abstract
Structure and function of therapeutic antibodies can be modulated by a variety of post-translational modifications (PTM). Tyrosine (Tyr) sulfation is a type of negatively charged PTM that occurs during protein trafficking through the Golgi. In this study, we discovered that an anti-interleukin (IL)-4 [...] Read more.
Structure and function of therapeutic antibodies can be modulated by a variety of post-translational modifications (PTM). Tyrosine (Tyr) sulfation is a type of negatively charged PTM that occurs during protein trafficking through the Golgi. In this study, we discovered that an anti-interleukin (IL)-4 human IgG1, produced by transiently transfected HEK293 cells, contained a fraction of unusual negatively charged species. Interestingly, the isolated acidic species exhibited a two-fold higher affinity to IL-4 and a nearly four-fold higher potency compared to the main species. Mass spectrometry (MS) showed the isolated acidic species possessed an +80-Dalton from the expected mass, suggesting an occurrence of Tyr sulfation. Consistent with this hypothesis, we show the ability to control the acidic species during transient expression with the addition of Tyr sulfation inhibitor sodium chlorate or, conversely, enriched the acidic species from 30% to 92% of the total antibody protein when the IL-4 IgG was co-transfected with tyrosylprotein sulfotransferase genes. Further MS and mutagenesis analysis identified a Tyr residue at the light chain complementarity-determining region-1 (CDRL-1), which was sulfated specifically. These results together have demonstrated for the first time that Tyr sulfation at CDRL-1 could modulate antibody binding affinity and potency to a human immune cytokine. Full article
(This article belongs to the Section Biochemistry)
Show Figures

Figure 1

18 pages, 4104 KiB  
Article
Generation and Characterization of SORT1-Targeted Antibody–Drug Conjugate for the Treatment of SORT1-Positive Breast Tumor
by Weiliang Zhuang, Wei Zhang, Liping Xie, Lei Wang, Yuan Li, Ziyu Wang, Ao Zhang, Haitao Qiu, Jun Feng, Baohong Zhang and Youjia Hu
Int. J. Mol. Sci. 2023, 24(24), 17631; https://doi.org/10.3390/ijms242417631 - 18 Dec 2023
Cited by 6 | Viewed by 3425
Abstract
Antibody–drug conjugates (ADCs) have greatly improved the outcomes of advanced breast tumors. However, the treatment of breast tumors with existing ADCs is still hindered by many issues, such as tumor antigen heterogeneity and drug resistance. Therefore, ADCs against new targets would provide options [...] Read more.
Antibody–drug conjugates (ADCs) have greatly improved the outcomes of advanced breast tumors. However, the treatment of breast tumors with existing ADCs is still hindered by many issues, such as tumor antigen heterogeneity and drug resistance. Therefore, ADCs against new targets would provide options for the treatment of these challenges. Sortilin-1 (SORT1) may be a promising target for ADC as it is upregulated in breast cancer. To evaluate the possibility of SORT1 as an ADC target, a humanized antibody_8D302 with high affinity against SORT1 was generated. Additionally, 8D302 was conjugated with MMAE and DXd to generate two ADCs_8D302-MMAE and 8D302-DXd, respectively. Both 8D302-MMAE and 8D302-DXd showed effective cytotoxicity against SORT1 positive breast tumor cell lines and induced bystander killing. Consequently, 8D302-MMAE showed relatively better anti-tumor activity than 8D302-DXd both in vitro and in vivo, but 8D302-DXd had superior safety profile and pharmacokinetics profile over 8D302-MMAE. Furthermore, SORT1 induced faster internalization and lysosomal trafficking of antibodies and had a higher turnover compared with HER2. Also, 8D302-DXd exhibited superior cell cytotoxicity and tumor suppression over trastuzumab-DXd, a HER2-targeted ADC. We hypothesize that the high turnover of SORT1 enables SORT1-targeted ADC to be a powerful agent for the treatment of SORT1-positive breast tumor. Full article
Show Figures

Figure 1

18 pages, 2689 KiB  
Article
Modeling the Immune Response for Pathogenic and Nonpathogenic Orthohantavirus Infections in Human Lung Microvasculature Endothelial Cells
by Evan P. Williams, Aadrita Nandi, Victoria Nam, Linda J. S. Allen, A. Alexandre Trindade, Michele M. Kosiewicz and Colleen B. Jonsson
Viruses 2023, 15(9), 1806; https://doi.org/10.3390/v15091806 - 24 Aug 2023
Viewed by 1775
Abstract
Hantaviruses, genus Orthohantavirus, family Hantaviridae, order Bunyavirales, are negative-sense, single-stranded, tri-segmented RNA viruses that persistently infect rodents, shrews, and moles. Of these, only certain virus species harbored by rodents are pathogenic to humans. Infection begins with inhalation of virus particles [...] Read more.
Hantaviruses, genus Orthohantavirus, family Hantaviridae, order Bunyavirales, are negative-sense, single-stranded, tri-segmented RNA viruses that persistently infect rodents, shrews, and moles. Of these, only certain virus species harbored by rodents are pathogenic to humans. Infection begins with inhalation of virus particles into the lung and trafficking to the lung microvascular endothelial cells (LMVEC). The reason why certain rodent-borne hantavirus species are pathogenic has long been hypothesized to be related to their ability to downregulate and dysregulate the immune response as well as increase vascular permeability of infected endothelial cells. We set out to study the temporal dynamics of host immune response modulation in primary human LMVECs following infection by Prospect Hill (nonpathogenic), Andes (pathogenic), and Hantaan (pathogenic) viruses. We measured the level of RNA transcripts for genes representing antiviral, proinflammatory, anti-inflammatory, and metabolic pathways from 12 to 72 h with time points every 12 h. Gene expression analysis in conjunction with mathematical modeling revealed a similar profile for all three viruses in terms of upregulated genes that partake in interferon signaling (TLR3, IRF7, IFNB1), host immune cell recruitment (CXCL10, CXCL11, and CCL5), and host immune response modulation (IDO1). We examined secreted protein levels of IFN-β, CXCL10, CXCL11, CCL5, and IDO in two male and two female primary HLMVEC donors at 48 and 60 h post infection. All three viruses induced similar levels of CCL5, CXCL10, and CXCL11 within a particular donor, and the levels were similar in three of the four donors. All three viruses induced different protein secretion levels for both IFN-β and IDO and secretion levels differed between donors. In conclusion, we show that there was no difference in the transcriptional profiles of key genes in primary HLMVECs following infection by pathogenic and nonpathogenic hantaviruses, with protein secretion levels being more donor-specific than virus-specific. Full article
Show Figures

Figure 1

35 pages, 363 KiB  
Article
Experiences of Faith-Based Organizations as Key Stakeholders in Policy Responses to Human Trafficking
by Charles Hounmenou
Societies 2023, 13(8), 193; https://doi.org/10.3390/soc13080193 - 16 Aug 2023
Cited by 1 | Viewed by 5420
Abstract
Faith-based organizations (FBOs) are substantially involved in the anti-human trafficking movement. Yet, limited research is available on their crucial roles in the field. This study explored their input in anti-trafficking policy implementation in the US by examining their motivations to engage in anti-human [...] Read more.
Faith-based organizations (FBOs) are substantially involved in the anti-human trafficking movement. Yet, limited research is available on their crucial roles in the field. This study explored their input in anti-trafficking policy implementation in the US by examining their motivations to engage in anti-human trafficking work, their distinctive competencies as stakeholders, and their experiences and challenges in providing anti-human trafficking services. A purposive sample of 16 leaders from 14 FBOs with anti-human trafficking work experience was recruited. A semi-structured interview guide was used to collect data. A thematic analysis of the data was conducted. The findings showed that FBOs have experience in various aspects of prevention, protection, and even assistance in prosecuting human trafficking cases and at multiple levels of intervention. The distinctive capacities of FBOs for policy advocacy, training, and housing services for trafficking survivors provide a glimpse of their leading roles in human trafficking policy implementation. Operating primarily outside public funding allows FBOs to develop short-term and long-term services for trafficking survivors without time constraints. The FBOs in the study reported using a non-discriminatory, survivor-centered, and trauma-informed approach in their anti-human trafficking service delivery. All the respondents in the study concurred that efforts by any FBOs to convert trafficking survivors to a particular faith are unethical and counterproductive. The implications for practice, policy implementation, and research are discussed. Full article
18 pages, 2539 KiB  
Article
Identification of Small Molecules Affecting the Secretion of Therapeutic Antibodies with the Retention Using Selective Hook (RUSH) System
by Mathilde Coulet, Sylvie Lachkar, Marion Leduc, Marc Trombe, Zelia Gouveia, Franck Perez, Oliver Kepp, Guido Kroemer and Stéphane Basmaciogullari
Cells 2023, 12(12), 1642; https://doi.org/10.3390/cells12121642 - 16 Jun 2023
Cited by 1 | Viewed by 3395
Abstract
Unlocking cell secretion capacity is of paramount interest for the pharmaceutical industry focused on biologics. Here, we leveraged retention using a selective hook (RUSH) system for the identification of human osteosarcoma U2OS cell secretion modulators, through automated, high-throughput screening of small compound libraries. [...] Read more.
Unlocking cell secretion capacity is of paramount interest for the pharmaceutical industry focused on biologics. Here, we leveraged retention using a selective hook (RUSH) system for the identification of human osteosarcoma U2OS cell secretion modulators, through automated, high-throughput screening of small compound libraries. We created a U2OS cell line which co-expresses a variant of streptavidin addressed to the lumen-facing membrane of the endoplasmic reticulum (ER) and a recombinant anti-PD-L1 antibody. The heavy chain of the antibody was modified at its C-terminus, to which a furin cleavage site, a green fluorescent protein (GFP), and a streptavidin binding peptide (SBP) were added. We show that the U2OS cell line stably expresses the streptavidin hook and the recombinant antibody bait, which is retained in the ER through the streptavidin–SBP interaction. We further document that the addition of biotin to the culture medium triggers the antibody release from the ER, its trafficking through the Golgi where the GFP-SBP moiety is clipped off, and eventually its release in the extra cellular space, with specific antigen-binding properties. The use of this clone in screening campaigns led to the identification of lycorine as a secretion enhancer, and nigericin and tyrphostin AG-879 as secretion inhibitors. Altogether, our data support the utility of this approach for the identification of agents that could be used to improve recombinant production yields and also for a better understanding of the regulatory mechanism at work in the conventional secretion pathway. Full article
Show Figures

Figure 1

16 pages, 315 KiB  
Article
“Human Trafficking Is Modern Day Slavery”: Rev. Margaret Fowler, Sex Work and Trafficking
by Anna K. Perkins and Dane C. Lewis
Religions 2023, 14(6), 687; https://doi.org/10.3390/rel14060687 - 23 May 2023
Cited by 1 | Viewed by 3301
Abstract
The late Rev. Margaret Fowler, United Church Minister, was a key supporter of LGBTQ rights and a vocal advocate against human trafficking in Jamaica. As the founder of the Theodora Project, Rev. Fowler served many persons coerced into sex work or subject to [...] Read more.
The late Rev. Margaret Fowler, United Church Minister, was a key supporter of LGBTQ rights and a vocal advocate against human trafficking in Jamaica. As the founder of the Theodora Project, Rev. Fowler served many persons coerced into sex work or subject to sexual exploitation. She argued that human trafficking is a complex connection of economy, gender, social dynamics, law, and foreign relations. She called for the Church to be involved in anti-trafficking work as to do nothing risks “the very real possibility of Jamaica becoming another major area of sex tourism”. As we celebrate her life and ministry, we are given the opportunity to carefully excavate her perspective on the nexus among trafficking, slavery, and sex work. It does appear that her discourse follows the traditional Church line, which conflates slavery, trafficking and sex work in a fashion that views sex work as wholly coerced. In exploring the arguments that validated her important ministry in Negril, this chapter centres sex positive approaches to sex work and questions the slavery and exploitation framing that is normal in Christian discourse. Full article
(This article belongs to the Special Issue Critical Perspectives on Religion, Sex, and Human Trafficking)
11 pages, 231 KiB  
Concept Paper
Understanding and Pursuing Labor Trafficking Cases Collaboratively
by Derek J. Marsh
Societies 2023, 13(4), 85; https://doi.org/10.3390/soc13040085 - 30 Mar 2023
Cited by 2 | Viewed by 3552
Abstract
The disparity between sex and labor federal prosecutions in the United States underscores the significant degree to which labor trafficking investigations and prosecutions have been marginalized since the Trafficking Victims Protection Act (TVPA) was enacted in 2000 in the United States. This article [...] Read more.
The disparity between sex and labor federal prosecutions in the United States underscores the significant degree to which labor trafficking investigations and prosecutions have been marginalized since the Trafficking Victims Protection Act (TVPA) was enacted in 2000 in the United States. This article focuses on the issue of labor trafficking and considers the importance of collaborating with multi-agency, multi-jurisdictional organizations to successfully pursue labor trafficking cases. Labor trafficking in the United States is defined, the importance of executive leadership support is reviewed, and suggestions for stakeholders to proactively identify potential foreign national and domestic labor trafficking cases are explored using the barrier model. A discussion of the trauma experienced by labor trafficking victims is made to further underscore the importance of including service providers in anti-labor trafficking collaborations. Full article
12 pages, 12727 KiB  
Article
An Efficient Humanized Mouse Model for Oral Anti-Retroviral Administration
by Amber K. Virdi, Sang Ho, Melanie S. Seaton, Arnold Z. Olali, Srinivas D. Narasipura, Hannah J. Barbian, Leannie J. Olivares, Hemil Gonzalez, Lee C. Winchester, Anthony T. Podany, Ryan D. Ross, Lena Al-Harthi and Jennillee Wallace
Cells 2023, 12(7), 1034; https://doi.org/10.3390/cells12071034 - 28 Mar 2023
Cited by 3 | Viewed by 3187
Abstract
HIV anti-retrovirals (ARVs) have vastly improved the life expectancy of people living with HIV (PLWH). However, toxic effects attributed to long-term ARV use also contribute to HIV-related co-morbidities such as heart disease, bone loss and HIV-associated neurocognitive disorders (HAND). Unfortunately, mouse models used [...] Read more.
HIV anti-retrovirals (ARVs) have vastly improved the life expectancy of people living with HIV (PLWH). However, toxic effects attributed to long-term ARV use also contribute to HIV-related co-morbidities such as heart disease, bone loss and HIV-associated neurocognitive disorders (HAND). Unfortunately, mouse models used to study the effects of ARVs on viral suppression, toxicity and HIV latency/tissue reservoirs have not been widely established. Here, we demonstrate an effective mouse model utilizing immune-compromised mice, reconstituted with infected human peripheral blood mononuclear cell (PBMCs). ARVs areincorporated into mouse chow and administered daily with combination ARV regimens includingAtripla (efavirenz, tenofovir disoproxil fumarate, and emtricitabine) and Triumeq (abacavir, dolutegravir and lamivudine). This model measures HIV-infected human cell trafficking, and ARV penetration throughout most relevant HIV organs and plasma, with a large amount of trafficking to the secondary lymphoid organs. Furthermore, the HIV viral load within each organ and the plasma was reduced in ARV treated vs. untreated control. Overall, we have demonstrated a mouse model that is relatively easy and affordable to establish and utilize to study ARVs’ effect on various tissues, including the co-morbid conditions associated with PLWH, such as HAND, and other toxic effects. Full article
(This article belongs to the Special Issue Therapeutic Mechanism of Nervous System Inflammation)
Show Figures

Figure 1

Back to TopTop